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Positive and negative regulation by SLP-76/ADAP 
and Pyk2 of chemokine-stimulated T-lymphocyte 
adhesion mediated by integrin α4β1
ABSTRACT Stimulation by chemokines of integrin α4β1–dependent T-lymphocyte adhesion 
is a crucial step for lymphocyte trafficking. The adaptor Vav1 is required for chemokine-acti-
vated T-cell adhesion mediated by α4β1. Conceivably, proteins associating with Vav1 could 
potentially modulate this adhesion. Correlating with activation by the chemokine CXCL12 of 
T-lymphocyte attachment to α4β1 ligands, a transient stimulation in the association of Vav1 
with SLP-76, Pyk2, and ADAP was observed. Using T-cells depleted for SLP-76, ADAP, or 
Pyk2, or expressing Pyk2 kinase–inactive forms, we show that SLP-76 and ADAP stimulate 
chemokine-activated, α4β1-mediated adhesion, whereas Pyk2 opposes T-cell attachment. 
While CXCL12-promoted generation of high-affinity α4β1 is independent of SLP-76, ADAP, 
and Pyk2, the strength of α4β1-VCAM-1 interaction and cell spreading on VCAM-1 are tar-
gets of regulation by these three proteins. GTPase assays, expression of activated or domi-
nant-negative Rac1, or combined ADAP and Pyk2 silencing indicated that Rac1 activation by 
CXCL12 is a common mediator response in SLP-76–, ADAP-, and Pyk2-regulated cell adhe-
sion involving α4β1. Our data strongly suggest that chemokine-stimulated associations be-
tween Vav1, SLP-76, and ADAP facilitate Rac1 activation and α4β1-mediated adhesion, 
whereas Pyk2 opposes this adhesion by limiting Rac1 activation.
INTRODUCTION
Trafficking of T-lymphocytes from blood circulation to lymphoid 
 tissue and to sites of injury and infection depends on rapid and 
 transient activation of αLβ2 and α4β1 integrin function by chemo-
kines located on the endothelium and inside tissues (Luster et al., 
2005; Ley et al., 2007). Following the binding of chemokines to their 
receptors, an inside-out signaling that impinges on the cytoplasmic 
domains of integrins is generated (Thelen and Stein, 2008). The final 
consequence of this signaling is the generation of high-affinity extra-
cellular αLβ2- and α4β1-integrin conformations that are competent 
for binding to their ligands ICAM-1 and VCAM-1, respectively, which 
are expressed on lymphoid or inflamed endothelium, and also facili-
tates α4β1 interaction with the CS-1 region of tissue fibronectin.
While talin binding to cytoplasmic motifs on β1- and β2-integrin 
subunits represents a common and central event for transmission of 
inside-out signaling from chemokine receptors to generate active 
α4β1 and αLβ2 (Moser et al., 2009b; Hogg et al., 2011; Kim et al., 
2011; Calderwood et al., 2013), important differences exist in the 
molecular pattern of this signaling to either integrin. αLβ2-dependent 
leukocyte adhesion stimulated through inside-out signaling shows a 
crucial requirement for kindlin 3, another important β subunit–bind-
ing protein, and to a lesser extent for α4β1 (Malinin et al., 2009; 
Manevich-Mendelson et al., 2009; Moser et al., 2009a; Svensson 
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tissues (Berlin-Rufenach et al., 1999), thus highlighting the structural 
and functional differences between α4β1 and αLβ2. The role of SLP-
76, ADAP, and Pyk2 in chemokine-activated T-cell adhesion medi-
ated by α4β1 has not yet been addressed. In the present work, we 
have studied the potential involvement of these signaling molecules 
in T-lymphocyte adhesion dependent on α4β1.
RESULTS
Role of SLP-76, ADAP, and Pyk2 on chemokine-activated 
T-cell adhesion mediated by α4β1
Coimmunoprecipitation analyses using anti–SLP-76 monoclonal an-
tibody (mAb) revealed that CXCL12 stimulates a transient increase 
in SLP-76 association with Vav1 and ADAP (Figure 1A). In agreement 
with previous work (Fischer et al., 1998), talin was found in anti–SLP-
76 immunoprecipitates, and CXCL12 also up-regulated this associa-
tion. No β1-integrin subunit was found in anti–SLP-76 immunopre-
cipitates (unpublished data). Cell fractionation experiments showed 
that SLP-76 is mainly found on the membrane-associated fraction, 
and its localization was not altered by CXCL12 (Supplemental Figure 
S1A). Instead, ADAP mostly displayed a cytosolic localization in 
nonstimulated cells, but it was rapidly and transiently recruited to 
the membrane following incubation with CXCL12, coincident with 
the stimulation by this chemokine of SLP-76-ADAP association.
To study potential connections between SLP-76 and ADAP in 
chemokine-activated T-cell adhesion involving α4β1, we knocked 
them down using RNA interference in Molt-4 and peripheral blood 
T-lymphocytes (PBL-T). SLP-76 was depleted with a pool of SLP-76 
small interfering RNA (siRNA; see Materials and Methods), whereas 
ADAP was found to be more efficiently silenced by ADAP-2 than 
ADAP-1 siRNA (Figure 1B), and we therefore used ADAP-2 siRNA to 
carry out the subsequent functional assays. Control experiments indi-
cated that SLP-76 or ADAP depletion did not affect cell viability or the 
expression of CXCR4, α4 or β1 (unpublished data). ADAP knocking 
down did not alter the coprecipitation between Vav1 and SLP-76 in 
nonstimulated cells (t = 0), but their increased association in CXCL12-
incubated cells was delayed and of smaller magnitude (Figure 1C), 
suggesting that a critical level of ADAP expression and/or its localiza-
tion was needed for enhanced Vav1-SLP-76 association.
Previous data showed that the kinase Pyk2 binds to the SH3 do-
main of Vav1 in Jurkat T-cells (Katagiri et al., 2000). Likewise, Vav1 
associated with Pyk2 in Molt-4 cells, and CXCL12 triggered a tran-
sient increase in Vav1-Pyk2 binding (Figure 1D, top, and Supple-
mental Figure S1B), in line with previous findings (Okabe et al., 
2005). In addition, low amounts of SLP-76 were also detected in 
anti-Pyk2 immunoprecipitates. ADAP was minimally detected only 
in Pyk2 immunoprecipitates from cells not exposed to CXCL12 (un-
published data). Furthermore, we found that Vav1-Pyk2 coimmuno-
precipitation was independent of SLP-76 or ADAP, as this associa-
tion was similarly detected in control, SLP-76 (Supplemental Figure 
S1C, left), or ADAP siRNA transfectants (unpublished data). Interest-
ingly, antibodies to talin, an additional Vav1 binding partner (Fischer 
et al., 1998; Garcia-Bernal et al., 2009), coprecipitated Pyk2 in addi-
tion to Vav1 in Molt-4 and PBL-T (Figure 1D, bottom). Supporting 
the specificity of talin-Pyk2 assembly, talin-Pyk2 coprecipitation was 
diminished in Pyk2 knockdown cells (Figure 1, E and F). Whether 
Pyk2 directly binds to talin, as in FAK-talin interaction (Mitra et al., 
2005), or indirectly through its association with Vav1 has not been 
addressed in the present study. In addition, Pyk2 knocking down did 
not significantly alter Vav1-talin association or CXCL12-promoted 
Vav1-talin dissociation (Figure 1G), an event contributing to the ini-
tial steps of α4β1-mediated T-cell adhesion (Garcia-Bernal et al., 
2009). Moreover, Vav1 and SLP-76 (Supplemental Figure S1C, right) 
et al., 2009). Of note, the RAPL-Rap1 and Rho/Rac-phospholipase D 
pathways are critical for chemokine-stimulated T-cell adhesion in-
volving αLβ2, with no or lesser roles in α4β1-mediated adhesion 
(Katagiri et al., 2003; Ghandour et al., 2007; Bolomini-Vittori et al., 
2009). Instead, the Vav1-Rac1 pathway is required for T-cell adhesion 
involving α4β1 upon exposure to chemokines (Garcia-Bernal et al., 
2005). Vav1 is a multidomain adaptor protein that functions as a gua-
nine nucleotide exchange factor (GEF) predominantly for the Rac1 
GTPase (Bustelo, 2000; Turner and Billadeau, 2002; Tybulewicz, 
2005). In T-cells, chemokine-induced, ZAP-70–dependent Vav1 tyro-
sine phosphorylation and Vav1 dissociation from talin represent an 
important event involved in α4β1 activation and in adhesion 
strengthening mediated by this integrin (Garcia-Bernal et al., 2009).
Vav1 binds key molecules involved in T-lymphocyte activation, 
such as SLP-76 and Pyk2 (Tuosto et al., 1996; Wu et al., 1996; 
Katagiri et al., 2000; Gismondi et al., 2003). SLP-76 is an adaptor 
molecule that is essential for T-cell activation and actin reorganiza-
tion following T-cell receptor (TCR) stimulation (Koretzky et al., 
2006). On TCR activation, ZAP-70–mediated phosphorylation of 
SLP-76 on N-terminal tyrosine residues allows its binding to the SH2 
domain of Vav1 (Tuosto et al., 1996; Wu et al., 1996; Raab et al., 
1997), whereas the C-terminal SH2 domain of SLP-76 interacts with 
several tyrosines on ADAP (da Silva et al., 1997; Musci et al., 1997; 
Geng et al., 1999; Boerth et al., 2000), a key molecule that also 
regulates T-cell activation (Griffiths and Penninger, 2002).
Pyk2 is a non receptor tyrosine kinase that is homologous to FAK 
(Avraham et al., 1995; Lev et al., 1995; Sasaki et al., 1995) and is 
activated following TCR stimulation and cell exposure to chemoat-
tractants (Dikic et al., 1996; Davis et al., 1997; Ganju et al., 1997; 
Qian et al., 1997). Early data showed that Pyk2 is capable of associ-
ating with Vav1 in T and NK cells (Katagiri et al., 2000; Gismondi 
et al., 2003; Gao and Blystone, 2009). There are three Pyk2 isoforms 
of 110 kDa, 105 kDa, and a third species called PRNK (Pyk2-related 
nonkinase) that only contains 238 amino acids from the C-terminus 
and lacks the catalytic and N-terminal regions (Xiong et al., 1998; 
Ivankovic-Dikic et al., 2000). A Tyr-402 residue is a target of Pyk2 
autophosphorylation, which in turns recruits and activates Src 
 kinases, leading to Src-dependent phosphorylation of several tyro-
sine residues on Pyk2 (Dikic et al., 1996; Li et al., 1999; Avraham 
et al., 2000).
The role of SLP-76, ADAP, and Pyk2 in integrin-mediated T-lym-
phocyte adhesion has been mostly studied in TCR-activated cells. 
Thus SLP-76 mediates αLβ2-dependent T-cell adhesion in response 
to TCR stimulation (Baker et al., 2009; Horn et al., 2009). In addition, 
it has been demonstrated that ADAP is required for TCR-stimulated 
cell adhesion mediated by β1 and β2 integrins (Griffiths et al., 2001; 
Peterson et al., 2001), a process regulated by an ADAP/SKAP-55 
signaling module (Wang et al., 2003, 2007; Kliche et al., 2006). As 
for Pyk2, its tyrosine phosphorylation as a consequence of integrin-
dependent outside-in signaling was earlier demonstrated (Li et al., 
1996; van Seventer et al., 1998; Zheng et al., 1998), and it was 
shown that Pyk2 regulates TCR-stimulated, LFA-1–dependent CD8+ 
cell adhesion (Beinke et al., 2010).
Little is known on the potential involvement of SLP-76 and Pyk2, 
as well as of ADAP, in chemokine-stimulated T-cell adhesion depen-
dent on integrins. For instance, SLP-76 is required for optimal 
T-lymphocyte arrest on ICAM-1 under flow conditions (Lee et al., 
2012). In addition, it has been recently shown that CCR7-mediated 
αLβ2 functions in T-cells are regulated by two independent ADAP/
SKAP55 modules (Kliche et al., 2012). The integrin α4β1 is espe-
cially involved in chemokine-stimulated T-lymphocyte trafficking to 
sites of inflammation, with lesser roles in cell migration to lymphoid 
Volume 26 September 15, 2015 Control of α4β1-mediated cell adhesion | 3217 
lymphocyte adhesion to VCAM-1 is especially relevant under shear 
stress but hardly seen in static conditions, similar to what has been 
reported in CXCL12–up-regulated, αLβ2-dependent adhesion to 
ICAM-1 of J14 and SLP-76–depleted cells (Horn et al., 2009; Lee 
et al., 2012). Contrary to SLP-76 and ADAP silencing, Pyk2 knock-
down transfectants showed stronger cell arrest than control siRNA 
transfectants (Figure 3A). Control experiments indicated that adhe-
sion was abolished by pretreating cells with pertussis toxin (PTx; 
unpublished data).
Generation of α4β1 high-affinity conformations upon 
CXCL12 stimulation is independent of SLP-76, ADAP, 
or Pyk2 activities
Changes in adhesion to VCAM-1 following SLP-76, ADAP, or Pyk2 
depletion could arise from altered acquisition of integrin high-
affinity conformations. We used HUTS-21, a reporter mAb that rec-
ognizes a β1-integrin activation epitope, to analyze whether 
knockdown of these proteins affects the affinity of α4β1. Chemo-
kine-incubated SLP-76–, ADAP-, or Pyk2-depleted cells, as well as 
PRNK transfectants, showed no gross alterations in HUTS-21 bind-
ing (Figure 3, B and C). Control experiments revealed that all trans-
fectants retained similar degrees of HUTS-21 mAb binding upon 
exposure to Mn2+ (Figure 3, B and C), a positive control for integ-
rin-affinity regulation. These results indicate that chemokine-stimu-
lated high-affinity α4β1 does not require SLP-76, ADAP, or Pyk2 
functions.
To further examine a potential involvement of these three pro-
teins in early steps of CXCL12-stimulated, α4β1-dependent cell ad-
hesion, we used VCAM-1-Fc in soluble binding assays to determine 
the efficiency of α4β1-VCAM-1 interaction without the subsequent 
cell spreading step. Using short-incubation conditions to obtain a 
two- to threefold induction in VCAM-1-Fc binding (20-s stimulation 
with CXCL12 followed by 75-s incubation with VCAM-1-Fc; Garcia-
Bernal et al., 2005), we observed similar VCAM-1-Fc binding to SLP-
76–, ADAP-, or Pyk2-depleted cells relative to control siRNA trans-
fectants (Figure 3D, left), which was inhibited by 80% by PTx 
(unpublished data). When we tested longer incubations with VCAM-
1-Fc, we observed that while control and ADAP siRNA transfectants 
(Figure 3D, right) and SLP-76 knockdown cells (unpublished data) 
have maximal interaction with VCAM-1 between 2 and 3 min, after 
which binding decreases, Pyk2-depleted cells displayed a consis-
tent sustainment of α4β1-VCAM-1-Fc interaction that was inhibited 
by PTx. All transfectants displayed comparable VCAM-1-Fc binding 
upon exposure to Mn2+ (unpublished data). These results suggest 
that Pyk2 silencing allows a Gαi-dependent sustained signaling to 
regulate α4β1 avidity, which likely contributes to maintaining α4β1-
VCAM-1 interaction.
Role of SLP-76, ADAP, and Pyk2 in adhesion strengthening 
and spreading mediated by α4β1
To analyze the α4β1-dependent adhesion strength of transfectants 
depleted for SLP-76, ADAP, or Pyk2, we subjected cells that had 
been attached to VCAM-1/CXCL12 at 1 dyne/cm2 to detachment at 
sequential increases of shear stress. ADAP- and SLP-76–depleted 
PBL-T and Molt-4 transfectants, as well as J14 cells, were found to 
develop lower resistance to detachment at high shear stress than 
control siRNA transfectants, although ADAP silencing consistently 
led to higher detachment rates than SLP-76 knockdown (Figure 4, A 
and B). Instead, Pyk2-depleted T-cells exhibited higher resistance to 
detachment than control siRNA transfectants (Figure 4A).
In the adhesion process, cells undergo spreading after the 
strengthening of the adhesion. Both SLP-76– and ADAP-knockdown 
and SLP-76-talin (unpublished data) interactions were not altered 
following Pyk2 silencing. We also observed that Pyk2-depleted cells 
had similar Erk1/2 MAP kinase activation at early time points follow-
ing stimulation with CXCL12, but this activation was defective at the 
longest times tested (Supplemental Figure S1D). Instead, CXCL12-
promoted Akt stimulation was not altered in Pyk2-knockdown 
transfectants.
We next tested SLP-76–, ADAP-, and Pyk2-depleted T-cells in 
α4β1-mediated static cell adhesion assays. As chemokine–up-reg-
ulated T-cell attachment is rapid and transient (Grabovsky et al., 
2000), the adhesion assays to α4β1 ligands coimmobilized with 
chemokines were performed using short incubation times (2 min) 
upon a brief cell centrifugation (15 s) to place cells immediately in 
contact with ligands. Under these conditions, we observed that 
SLP-76–depleted Molt-4 and PBL-T had modest reductions in ad-
hesion to FN-H89 (CS-1/FN), whereas their attachment to VCAM-1 
displayed small but nonsignificant decreases compared with con-
trol siRNA transfectants (Figure 2A). Similarly, SLP-76–deficient J14 
cells displayed chemokine-promoted adhesion to VCAM-1 com-
parable with parental Jurkat cells, whereas activated adhesiveness 
of Lck-deficient JCaM1.6 cells was fully abrogated (Figure 2B), 
consistent with previous data (Feigelson et al., 2001). ADAP deple-
tion generally affected to a higher degree the stimulation of α4β1-
dependent T-cell attachment compared with SLP-76 knocking 
down (Figure 2A). In addition, ADAP-depleted Molt-4 cells exhib-
ited a substantial inhibition of CXCL12-triggered, α4β1-mediated 
migration across tumor necrosis factor α–treated HUVEC monolay-
ers under static conditions (Supplemental Figure S2), whereas 
transfectants knocked down for SLP-76 (Supplemental Figure S2) 
and J14 cells (unpublished data) displayed partial impairments in 
migration.
Of note, Pyk2 knocking down resulted in significant increases in 
chemokine-triggered T-cell adhesion to both FN-H89 and VCAM-1 
relative to control siRNA transfectants (Figure 2A). Instead, we were 
unable to detect alterations in attachment to ICAM-1 with CXCL12-
incubated, Pyk2-silenced cells (Figure 2C), in line with previous re-
sults using Pyk2−/− T-cells exposed to standard doses of anti-CD3 
antibodies (Beinke et al., 2010). Moreover, overexpression of PRNK, 
a Pyk2 C-terminal region isoform that lacks the kinase domain 
(Xiong et al., 1998) and inhibits the endogenous Pyk2 kinase activity, 
led to up-regulation of α4β1-dependent attachment of nonstimu-
lated T-cells, which achieved a further enhancement in the presence 
of CXCL12 (Figure 2D). In support of an involvement of Pyk2 kinase 
activity in the regulation of α4β1-mediated T-cell adhesion, we 
found that the expression of the Pyk2-K457A kinase–inactive mutant 
(Katagiri et al., 2000) resulted in a remarkable increase in cell attach-
ment to VCAM-1 (Figure 2E). Instead, mutation at the Tyr-402 Pyk2 
autophosphorylation site (Pyk2-Y402F) did not alter this adhesion. 
We were unable to use transfectants overexpressing wild-type Pyk2 
in the adhesion assays, as they displayed a high degree of cell death 
(unpublished data), consistent with previously reported data (Xiong 
and Parsons, 1997).
Next we carried out adhesion assays under flow conditions us-
ing SLP-76–, ADAP-, or Pyk2-depleted T-cells, measuring the cells 
that rapidly (< 20 s) and stably adhere under a shear stress of 
1 dyne/cm2 to VCAM-1 coimmobilized with CXCL12. Results re-
vealed that Molt-4 and PBL-T knocked down for SLP-76 or ADAP 
have a decrease (40–75%) in stable cell arrest on VCAM-1/CXCL12 
compared with control siRNA transfectants (Figure 3A). Confirming 
the involvement of SLP-76, J14 cells also displayed a significant re-
duction in cell arrest relative to parental Jurkat cells (Figure 3A). 
Therefore the contribution of SLP-76 in chemokine-stimulated 
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Molt-4 and PBL-T transfectants developed a 
time-dependent progressive reduction in 
the spreading on VCAM-1/CXCL12 com-
pared with control counterparts (Figure 4C, 
left and middle). On the contrary, Pyk2 
knockdown and PRNK transfectants dis-
played higher spreading than control cells 
(Figure 4C). These data indicate that ADAP 
and Pyk2 regulate the chemokine-stimu-
lated T-cell adhesion strengthening and 
spreading steps mediated by α4β1, whereas 
SLP-76 mainly contributes to cell spreading, 
with lesser roles in adhesion strengthening.
Rac1 involvement in SLP-76, ADAP, 
and Pyk2 regulation of CXCL12-
activated T-cell adhesion dependent 
on α4β1
The strength of α4β1-mediated adhesion 
and the subsequent spreading process in 
chemokine-stimulated T-cells depends on 
the activation of the GTPase Rac1 (Garcia-
Bernal et al., 2005). Compared with control 
cells, knocking down SLP-76 led to a less 
 efficient Rac1 activation in Molt-4 cells in 
 response to CXCL12, which was rapidly 
lost at the longest incubation time tested 
(Figure 5A, top). Moreover, CXCL12-ex-
posed J14 cells displayed no stimulation of 
Rac activation relative to parental Jurkat 
cells (Figure 5A, bottom). In addition, ADAP-
depleted transfectants displayed a blockade 
FIGURE 2: Chemokine-stimulated static adhesion of SLP-76, ADAP, or Pyk2 transfectants to 
α4β1 ligands. (A) Control, SLP-76–, ADAP-, or Pyk2-knockdown Molt-4 or PBL-T transfectants 
were subjected to adhesion assays to FN-H89 or VCAM-1 in the absence (Medium) or presence 
of coimmobilized CXCL12 or CCL21 (n = 3–5). (B) Parental Jurkat, J14, and JCaM1.6 cells were 
tested in adhesion assays to VCAM-1 as in A (n = 2). (C) Molt-4 cells were transfected with 
control or Pyk2 siRNA and transfectants tested in adhesion assays to ICAM-1 coimmobilized  
FIGURE 1: Chemokine-stimulated associations between Vav1, SLP-76, ADAP, and Pyk2. (A) Left, Molt-4 T-cells 
incubated for the indicated times with CXCL12 were subjected to immunoprecipitation with anti–SLP-76 followed by 
immunoblotting with antibodies to the indicated proteins. Right, bars represent densitometric quantification of gel 
bands showing the mean ± SD of six independent experiments (ΔΔΔ, p < 0.001; ΔΔ, p < 0.01; Δ, p < 0.05). (B) Top, cells 
were transfected with SLP-76, ADAP, or control siRNA, and expression of SLP-76 and ADAP was analyzed by 
immunoblotting. Control loading is shown by blotting with anti–β-actin antibodies. Bottom, densitometric quantification 
of gel bands showing the mean ± SD of four (Molt-4) or three (PBL-T) independent experiments. (C) CXCL12-incubated 
control or ADAP siRNA Molt-4 transfectants were assayed by immunoprecipitation with anti-Vav1 antibodies, followed 
by immunoblotting with antibodies to the proteins shown (ΔΔ, p < 0.01; Δ, p <0.05). (D) Cells were incubated in the 
absence or presence of CXCL12, and subsequently subjected to immunoprecipitation and Western blotting. (E) Left, 
Cells were transfected with Pyk2 or control siRNA, and transfectants were assayed by Western blotting at the indicated 
times. Right, densitometric analyses of gel bands showing the mean ± SD of three independent experiments. 
(F and G) Control or Pyk2 siRNA transfectants were subjected to immunoprecipitation with anti-talin antibodies, 
followed by immunoblotting with antibodies to the shown proteins. Talin-Vav1 coprecipitation was significantly 
diminished (**, p < 0.001; *, p < 0.05; n = 4).
with or without CXCL12 (n = 3). (D) Cells were 
transfected with empty (Mock) or PRNK 
vectors, and transfectants were tested by 
Western blotting for PRNK expression (left) 
or in adhesion assays (middle and right)  
(n = 4). (E) Cells were transfected with control 
GFP vector or with the indicated GFP-fused 
Pyk2 mutants, and transfectants were 
subjected to immunoblotting or to adhesion 
assays (n = 4). Adhesions were significantly 
inhibited (***, p < 0.001; **, p < 0.01; 
*, p < 0.05) or significantly stimulated  
(ΔΔΔ, p < 0.001; ΔΔ, p < 0.01; Δ, p <0.05)  
(n.s., nonsignificant).
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cells, SLP-76 knockdown in PBL-T resulted 
in inefficient Vav1 tyrosine phosphorylation 
in response to CXCL12, whereas phosphor-
ylation was not affected in ADAP-depleted 
cells (Figure 5E). Again, Pyk2-silenced PBL-T 
exhibited CXCL12-stimulated Vav1 tyrosine 
phosphorylation but of lower magnitude 
and less maintained than control siRNA 
transfectants (Figure 5E).
Next we tested the relevance of the defi-
cient Rac activation shown by SLP-76– and 
ADAP-deficient T-cells on their impaired ad-
hesion. For this, we transfected green fluo-
rescent protein (GFP)-fused, constitutively 
active forms of Rac (GFP-Rac V12) in J14 and 
parental Jurkat cells or expressed GFP-Rac 
V12 together with ADAP siRNA, and then 
we tested the transfectants in adhesion as-
says to VCAM-1 coimmobilized with 
CXCL12. Flow-chamber adhesion assays re-
vealed that the reduction in stable adhesion 
shown by J14-GFP cells relative to parental 
Jurkat-GFP was significantly rescued upon 
expression of GFP-Rac V12 (Figure 6A). Like-
wise, GFP-Rac V12 expression reversed the 
inhibitory effects of ADAP siRNA transfec-
tion on the stimulation of cell adhesion to 
VCAM-1/CXCL12 (Figure 6B). Moreover, the 
up-regulated adhesion to VCAM-1/CXCL12 
shown by Pyk2-knockdown Molt-4 and PBL-
T transfectants was partially reversed when 
dominant-negative, GFP-fused Rac1 (GFP-
Rac N17) was transfected together with Pyk2 
siRNA (Figure 6, C and D). These results 
strongly suggest that altered Rac1 activa-
tion in SLP-76–, ADAP-, or Pyk2-knockdown 
T-cells represents an important mechanism 
mediating their changes in chemokine-stim-
ulated, α4β1-dependent cell adhesion.
As the adhesion data indicate that T-cell 
attachment involving α4β1 is especially al-
tered upon knocking down ADAP or Pyk2, 
we next analyzed the effect of their combined 
depletion on cell adhesion to VCAM-1. Results revealed that the inef-
ficient stimulation of adhesion displayed by ADAP-silenced cells 
could be rescued by Pyk2 siRNA cotransfection, although the dou-
ble-knockdown transfectants did not reach the adhesion values ex-
hibited by cells transfected with Pyk2 siRNA alone (Figure 7A). In 
addition, the up-regulated cell attachment following Pyk2 silencing 
was not detected when both SLP-76 and Pyk2 were knocked down 
(Figure 7B), suggesting that cooperative responses between ADAP 
and SLP-76 exist during their positive regulation of α4β1-dependent 
T-cell adhesion. Similar to ADAP-Pyk2 siRNA cotransfection, PRNK 
transfection together with ADAP siRNA led to a recovery of adhesion 
to VCAM-1/CXCL12 (Figure 7C). Notably, the rescue in adhesion 
shown by cells knocked down for both ADAP and Pyk2 correlated 
with longer, sustained Rac1 activation in these transfectants (Figure 
7D). The small decrease in activation of Rac at early time points might 
reflect initial inhibition due to ADAP depletion that is later recovered 
by siPyk2 silencing. These results suggest that the stimulatory actions 
of ADAP and the inhibitory activity of Pyk2 during CXCL12-activated 
adhesion mediated by α4β1 are connected through Rac1.
of CXCL12-stimulated Rac activation (Figure 5B). Furthermore, inhibi-
tion of Rac activation in SLP-76– and ADAP-knockdown transfectants 
was associated with impaired stimulation by CXCL12 of F-actin po-
lymerization (Supplemental Figure S3A). In contrast, Pyk2 silencing 
led to a more sustained Rac1 activation and F-actin polymerization 
than control transfectants (Figure 5C and Supplemental Figure S3B).
Chemokine-stimulated Rac1 activation in T-cells was previously 
shown to involve Vav1 tyrosine phosphorylation (Garcia-Bernal 
et al., 2005). In SLP-76–silenced cells, impaired Rac1 activation was 
associated with a lower degree and less maintained chemokine-
promoted Vav1 tyrosine phosphorylation compared with control 
siRNA transfectants, whereas no gross alterations in Vav1 phosphor-
ylation were detected in ADAP-depleted cells (Figure 5D), similar to 
the unaltered Vav1 phosphorylation in ADAP knockout mice (Reyn-
olds et al., 2002). Furthermore, the CXCL12-triggered enhancement 
in Rac1 activation seen in Pyk2-silenced transfectants did not corre-
late with higher Vav1 tyrosine phosphorylation than control counter-
parts, and this phosphorylation generally displayed lower intensity 
compared with control transfectants (Figure 5D). Similar to Molt-4 
FIGURE 3: Flow-chamber adhesion assays and determination of high-affinity α4β1 expression in 
SLP-76–, ADAP-, or Pyk2-depleted T-cells. (A) Control, SLP-76, ADAP, or Pyk2 siRNA 
transfectants or Jurkat or J14 cells were perfused in flow chambers coated with VCAM-1 
coimmobilized with CXCL12 and analyzed for rolling and stable cell arrest (n = 3–4). Data are 
presented as mean ± SD of cell percentages from the total cell population. Adhesions were 
significantly inhibited or stimulated in comparison with those of control siRNA transfectants or 
parental Jurkat cells, *p < 0.05 or Δp < 0.05, respectively. (B and C) The indicated siRNA Molt-4 
transfectants or cells transfected with PRNK or empty vector were tested by flow cytometry for 
HUTS-21 mAb binding after stimulation with CXCL12 or Mn2+. (D) Following exposure to 
CXCL12 for 20 s, transfectants were analyzed by flow cytometry for VCAM-1-Fc binding after 
the indicated times. PTx denotes cells preincubated with pertussis toxin.
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proteins with Vav1, strongly suggesting that the dynamics of this 
protein module can regulate the extent of α4β1-mediated T-cell 
attachment.
Alterations in adhesion to α4β1 ligands exhibited by SLP-76–, 
ADAP-, or Pyk2-depleted cells were independent of changes in 
α4β1 affinity following CXCL12 stimulation. Rather, flow-chamber 
adhesion assays revealed that the strengthening of α4β1-dependent 
attachment was regulated by SLP-76 and ADAP, though the strength 
of ADAP-knockdown transfectant attachment was consistently lower 
than SLP-76–depleted counterparts. Moreover, we show that 
spreading on VCAM-1/CXCL12 was similarly decreased in T-cells 
silenced for SLP-76 and ADAP. Compared with the absolute require-
ment of talin and Vav1 in the control of α4β1 affinity and strength of 
DISCUSSION
Vav1 is needed for chemokine-stimulated T-cell adhesion involving 
α4β1 (Garcia-Bernal et al., 2005, 2009), and thus it is conceivable 
that Vav1-binding proteins such as SLP-76 and Pyk2 could modu-
late this process. Using Molt-4 and primary human PBL-T depleted 
for SLP-76 or for ADAP, an SLP-76–interacting partner, as well as 
SLP-76–deficient J14 cells, we show here that these two proteins 
contribute to optimal stimulation by CXCL12 of α4β1-mediated 
T-cell attachment under flow conditions. Instead, Pyk2 negatively 
regulates this adhesion, as its depletion or expression of kinase-
inactive Pyk2 forms led to increased cell attachment. Of note, mod-
ulation of cell adhesion by SLP-76, ADAP, and Pyk2 correlated with 
a chemokine-stimulated transient increase in association of these 
FIGURE 4: Analyses of T-cell adhesion strengthening and spreading on VCAM-1. The indicated siRNA transfectants 
(A) or Jurkat and J14 cells (B), preattached onto coimmobilized VCAM-1 and CXCL12 in flow chambers, were subjected 
to cell detachment after sequential increases of shear stress. Data show mean ± SD of cell percentages from the initial 
number of bound cells remaining attached at the indicated shear stresses (A, n = 4; B, n = 3). (C) Molt-4 and PBL-T were 
transfected with the indicated siRNA or vectors, and transfectants were allowed to attach to VCAM-1 immobilized with 
CXCL12. Spreading was evaluated from Nomarski images at the indicated times. Percentage of cell spreading was 
determined from cells (2500–3000) from different fields of view. Spreading was significantly inhibited (**, p < 0.01; 
*, p < 0.05) or stimulated (Δ, p < 0.05) compared with control siRNA or mock transfectants (n = 3). n.s., nonsignificant.
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FIGURE 5: Analyses of Rac1 activation and Vav1 tyrosine phosphorylation in SLP-76–, ADAP-, or Pyk2-deficient T-cells. 
Control, SLP-76, ADAP, or Pyk2 siRNA transfectants in Molt-4 cells, or Jurkat and J14 cells (A–C) were stimulated with 
CXCL12 and subjected to GTPase assays to detect Rac1 activation. Activation was significantly increased compared 
with untreated cells (ΔΔΔ, p < 0.001; ΔΔ, p < 0.01; Δ, p < 0.05; A, n = 7; B and C, n = 3). The indicated Molt-4 (D) 
or PBL-T (E) siRNA transfectants incubated with or without CXCL12 for the indicated times were analyzed by 
immunoprecipitation and Western blotting. Vav1 tyrosine phosphorylation was significantly up-regulated compared 
with untreated cells (ΔΔ, p < 0.01; Δ, p < 0.05; D, n = 6; E, left, n = 2; E, right, n = 3).
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FIGURE 6: Rac1 involvement in SLP-76, ADAP, and Pyk2 regulation of CXCL12-activated T-cell adhesion dependent on 
α4β1. (A) Cells were transfected with GFP or GFP-Rac V12 vectors and were analyzed by immunoblotting (top) or were 
subjected to flow-chamber adhesion assays to VCAM-1 coimmobilized with CXCL12 (bottom). Adhesion was 
significantly rescued in comparison with J14-GFP transfectants (Δ, p < 0.05; n = 3). (B) Molt-4 cells were transfected with 
the indicated siRNA and GFP vector combinations and were analyzed by Western blotting (top) or in static adhesion 
assays to VCAM-1 immobilized with or without CXCL12 (bottom). Adhesion was significantly inhibited (*, p < 0.05) or 
recovered (Δ, p < 0.05). (C and D) The indicated Molt-4 or PBL-T transfectants were tested by immunoblotting or were 
subjected to adhesion assays to VCAM-1 immobilized with or without CXCL12. Adhesion was significantly stimulated 
(ΔΔ, p < 0.01) or inhibited (*, p < 0.05) (B–D, n = 3).
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and ADAP likely function as adaptors with Vav1 to optimize che-
mokine-promoted Rac activation and stimulation of α4β1-
dependent cell adhesion. Instead, Pyk2 restricts this attachment 
by limiting Rac activation. As knocking down any of these three 
proteins influences the outcome of Rac activation, the data 
strongly suggest that depletion-mediated changes in the compo-
sition of the complex formed by Vav1, SLP-76, ADAP, and Pyk2 
could account for alterations in Rac activation. In this regard, we 
show that knocking down ADAP delays Vav1-SLP-76 association 
and impairs Rac activation in response to CXCL12, suggesting that 
the Vav1-SLP-76-ADAP module facilitates Rac1 activation upon 
chemokine stimulation and optimizes the strength and spreading 
of α4β1-mediated T-cell adhesion. On this point, SLP-76 assembly 
with Vav1 and Nck contributes to TCR-stimulated Rac1 activation 
(Bubeck Wardenburg et al., 1998; Barda-Saad et al., 2010), and 
importantly, ADAP associates with these complexes together with 
WASP (Krause et al., 2000; Coppolino et al., 2001) and cooperates 
with Nck in the recruitment of SLP-76 for regulation of Rho 
GTPase–mediated actin rearrangement (Pauker et al., 2011). 
Earlier results reported that SLP-76 depletion in Jurkat cells did 
not affect the CXCL12-stimulated Rac1 activation (Horn et al., 
2009). The basis for the discrepancies between these results and 
our observation of inefficient Rac1 activation by CXCL12 in SLP-
76–deficient cells is not known at present.
chemokine-activated T-cell attachment (Garcia-Bernal et al., 2006, 
2009; Manevich et al., 2007), the contribution of SLP-76 and ADAP 
in these processes appears to be of lesser magnitude. However, 
both adaptors are clearly needed to achieve optimal stability of this 
adhesion.
VCAM-1-Fc soluble binding to Pyk2-silenced cells was main-
tained longer than with control transfectants, suggesting that Pyk2 
can regulate the avidity of α4β1. Sustained VCAM-1 binding likely 
represents one of the mechanisms accounting for the stronger cell 
arrest and resistance to detachment under shear stress shown by 
Pyk2-knockdown cells relative to control counterparts. Associated 
with increased strength of attachment to VCAM-1/CXCL12 exhib-
ited by Pyk2-depleted cells, they displayed enhanced spreading, 
an observation in line with previous results showing high spread-
ing correlating with defective cell detachment of Pyk2−/− macro-
phages (Okigaki et al., 2003). Therefore our data indicate that 
Pyk2 negatively regulates the strength and spreading phases of 
chemokine-activated T-cell attachment involving α4β1.
Our previous results revealed that Vav1-mediated Rac1 activa-
tion in response to CXCL12 in T-cells represents an important 
event for strengthening of α4β1-VCAM-1 interaction, as well as for 
cell spreading (Garcia-Bernal et al., 2005). The present data indi-
cate that Rac1 is a common mediator of SLP-76–, ADAP-, and 
Pyk2-modulated T-cell adhesion to α4β1 ligands. Thus SLP-76 
FIGURE 7: Analysis of functional connections between ADAP and Pyk2 in CXCL12-stimulated adhesion mediated by 
α4β1. (A–C) Molt-4 cells were transfected with the indicated individual or combined siRNA and/or vectors, and 
transfectants were analyzed by immunoblotting or in adhesion assays to VCAM-1 immobilized with or without CXCL12. 
Adhesions were significantly inhibited (*p < 0.05) or significantly stimulated or rescued (ΔΔΔ, p < 0.001; ΔΔ, p < 0.01; or 
Δ, p < 0.05) (A, n = 4; B and C, n = 3). (D) The indicated transfectants were tested in GTPase assays to detect active Rac.
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was not as efficient as in control transfectants. These data reveal that 
SLP-76 and Pyk2 but not ADAP contribute to optimal Vav1 tyrosine 
phosphorylation in T-cells in response to CXCL12, and indicate that 
net Rac activation is the result of Vav1-dependent and Vav1-inde-
pendent mechanisms. It remains puzzling that inefficient Vav1 phos-
phorylation in SLP-76– and Pyk2-depleted T-cells led to opposite 
effects on Rac activation. The molecular basis underlying these dis-
tinct responses is not known at present. SLP-76 and Pyk2 knock-
down might similarly affect recruitment and/or activity of tyrosine 
kinases involved in Vav1 tyrosine phosphorylation, such as ZAP-70 
and Lck (Gulbins et al., 1993; Ottoson et al., 2001). But it is also clear 
that the subsequent Rac activation is differentially regulated and 
likely involves distinct GEFs and GTPase-activating proteins (GAPs). 
GEFs and GAPs that are known to regulate CXCL12-stimulated 
Rac activation and α4β1-mediated T-cell adhesion include the 
GEF DOCK2 and the GAP β-chimerin. Of note, lymphocytes 
from DOCK2 knockout mice display minimal chemokine-induced 
Rac activation compared with control cells (Fukui et al., 2001). 
Furthermore, we showed that DOCK2 cooperates with Vav1 for 
CXCL12-promoted Rac activation, and its silencing inhibits T-cell at-
tachment mediated by α4β1 under flow conditions (Garcia-Bernal 
et al., 2006). Instead, β-chimerin overexpression in T-cells results in 
impaired Rac activation in response to CXCL12 associated with inhi-
bition of α4β1-dependent T-cell adhesion (Siliceo et al., 2006). 
Although it has not yet been tested, the possibility exists that 
DOCK2 and β-chimerin might be recruited to the Vav1-Pyk2-SLP-
76-ADAP module, thus contributing to the regulation of Rac activity 
and subsequent cell attachment mediated by α4β1. Other GEFs 
and GAPs expressed on T-lymphocytes that are known to regulate 
Rac activation include PlekhG2, Pix, and ArhGAP15 (Seoh et al., 
2003; Phee et al., 2005; Runne and Chen, 2013), though their role in 
the control of α4β1-dependent T-cell adhesion has not been 
addressed.
SKAP-55 is an additional molecule that could modulate ADAP-
controlled T-cell attachment to α4β1 ligands following chemokine 
stimulation. Thus ADAP binds SKAP-55, an adaptor protein that 
mediates up-regulation of T-cell adhesion to 
ICAM-1 and fibronectin upon TCR activa-
tion (Marie-Cardine et al., 1998; Wang et al., 
2003, 2007). The ADAP-SKAP-55 module 
interacts with RIAM through SKAP-55, facili-
tating TCR-mediated integrin activation 
(Kliche et al., 2006; Menasche et al., 2007; 
Horn et al., 2009). Furthermore, indepen-
dent ADAP-SKAP-55 modules regulate 
CCR7-mediated αLβ2 functions in T-cells 
(Kliche et al., 2012), and recent data indicate 
that ADAP can also bind talin and kindlin to 
promote integrin-αIIbβ3 activation and fi-
brinogen binding (Kasirer-Friede et al., 
2014).Whether the ADAP-SKAP-55 associa-
tion contributes to chemokine-stimulated 
Rac activation and T-cell adhesion involving 
α4β1 is currently unknown.
A model can be proposed from the 
present results (Figure 8). The net Rac1 acti-
vation levels needed to develop sufficient 
adhesion strength and cell spreading medi-
ated by α4β1 are possibly the result of op-
posing activities inside the Vav1-SLP-76-
ADAP-Pyk2 module. Thus Pyk2 kinase 
activity would oppose the Rac1 activation 
Characterization of the mechanics of Pyk2-regulated, α4β1-
mediated cell attachment reveals that the Pyk2 kinase domain 
negatively controls this adhesion. Thus expression of PRNK, which 
lacks the Pyk2 kinase domain, as well as of a point mutant, kinase-
inactive Pyk2 form, mimicked the effects of Pyk2 depletion on the 
increase in α4β1-mediated attachment, strongly suggesting that 
Pyk2-dependent tyrosine phosphorylation activity in T-cells con-
tributes to keep Rac1 activation levels under control. Of note, 
negative regulation of Rac activation and cell adhesion to VCAM-1 
by Pyk2 directly opposed the stimulatory activity of ADAP in these 
processes, as detected in cells silenced for both proteins. In this 
experimental setting, the absence of Pyk2 might rescue the activa-
tion of Rac1 concurrent with the inhibitory effects of ADAP knock-
down, leading to stimulation of adhesion to VCAM-1, but we can-
not exclude that recovery of these activities occurs subsequent to 
the negative actions of ADAP depletion. Our data are in line with 
early work proposing that Pyk2 regulates Rac1 activation (Tokiwa 
et al., 1996) and with results showing that macrophages from mice 
knocked out for the Pyk2 closely related kinase FAK have elevated 
Rac activation (Owen et al., 2007). However, the level of activation 
of this GTPase based on Pyk2 activity might be cell-context de-
pendent (Chapman and Houtman, 2014), as NK cells expressing a 
kinase-dead Pyk2 displayed reduced Rac activation (Gismondi 
et al., 2003).
CXCL12 promotes tyrosine phosphorylation of Vav1 associated 
with Rac1 activation and stimulation of α4β1-mediated T-cell adhe-
sion (Garcia-Bernal et al., 2005). Inefficient phosphorylation of Vav1 
in response to CXCL12 in SLP-76–depleted T-cells correlated with 
their impaired Rac activation, whereas ADAP-knockdown cells dis-
played fully competent chemokine-promoted phosphorylation of 
this GEF, in spite of their defective Rac activation. These results 
might reflect the fact that ADAP does not directly interact with Vav1 
but associates with the Vav1-SLP-76 module, possibly in a SLP-76–
dependent manner. Interestingly, the increased Rac activation fol-
lowing CXCL12 stimulation in Pyk2-silenced cells was not coupled 
with enhanced Vav1 phosphorylation, but rather phosphorylation 
FIGURE 8: Model for regulation by Vav1-associated proteins of chemokine-stimulated, 
α4β1-dependent T-cell adhesion. Rac1 activation by CXCL12 is a well-known event for 
stimulation of the adhesion strength and spreading mediated by α4β1 in T-cells. A transient 
complex formed by Vav1, SLP-76, ADAP, and Pyk2 regulates this adhesion. While Vav1-SLP-76-
ADAP stimulates chemokine-promoted Rac1 activation (green arrow), the presence of Pyk2 in 
the complex opposes this activation (red blocking symbol). The result of these opposing actions 
is a net Rac activation and up-regulation of T-cell adhesion strengthening and spreading 
dependent on α4β1. Talin can also be found in this complex, perhaps as an independent pool 
from β1-associated talin. Its role in the assembly and function of this complex has not been 
addressed in the present study.
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stimulated by Vav1-SLP-76-ADAP and possibly additional costimu-
latory molecules, potentially by activating a GAP or by inhibiting a 
GEF for Rac1. Talin can also be found in this protein module, but its 
role in the stability and function of the complex and whether it rep-
resents a different pool from β1-associated talin has not been ad-
dressed here. Furthermore, the present data, together with our 
previous results (Garcia-Bernal et al., 2009), raise the possibility that 
separate pools of SLP-76 with either Vav1 or talin might exist. Our 
data should add molecular mechanistic insights into the process of 
chemokine-stimulated T-cell adhesion mediated by α4β1, a key 
step during T-lymphocyte trafficking to sites of inflammation.
MATERIALS AND METHODS
Cells, antibodies, and reagents
The human Molt-4 and Jurkat T-cell lines were cultured in RPMI 
1640 medium (Lonza, Verviers, Belgium) and 10% fetal bovine se-
rum (Life Technologies, Paisley, UK) (complete medium). The Jur-
kat-derived cell lines JCaM1.6 (American Type Culture Collection) 
and J14 (a gift from Arthur Weiss, University of California, San 
Francisco, CA) were grown in complete medium. Peripheral blood 
T-lymphocytes (PBL-T) were prepared as previously described 
(Garcia-Bernal et al., 2005). The Consejo Superior de Investigacio-
nes Científicas Ethics Committee (Madrid, Spain) approved the 
protocols used to obtain and process the human blood samples. 
Control P3×63 and anti–β1 TS2/16 mAb were gifts from Francisco 
Sánchez-Madrid (Hospital de la Princesa, Madrid, Spain), and poly-
clonal anti–β1A antibodies were from Guido Tarone (Turin Univer-
sity, Italy). Antibodies to SLP-76 and Vav1 (C14) were from Santa 
Cruz Biotechnology (Santa Cruz, CA), anti–phospho-Vav (Y174; 
ab47282) was from Abcam (Cambridge, MA), anti-Rac1 and anti-
ADAP were from BD Biosciences (San Diego, CA), and anti-GFP 
was from Molecular Probes (Eugene, OR). Antibodies to β-actin, 
vinculin, and talin clone 8D4 were from Sigma-Aldrich (St. Louis, 
MO), and antibody to Pyk2 was from Millipore (Billerica, MA). 
The HUTS-21 anti–β1 mAb has been previously characterized 
(Luque et al., 1996). CXCL12 was purchased from R&D Systems 
(Minneapolis, MN) and CCL21 was purchased from Peprotech 
(Rocky Hill, NJ).
Transfections and RNA interference
Vectors coding for Rac wild-type (wt), Rac V12, Rac N17, Pyk2-
Y402F, Pyk2-K457A, and Pyk2-wt fused with GFP were provided 
by Francisco Sánchez-Madrid. The vector pRK5-myc-PRNK 
(Ivankovic-Dikic et al., 2000) was a gift from Ivan Dikic (Goethe 
University School of Medicine, Frankfurt, Germany). The siRNA 
against human SLP-76 (ON-TARGETplus, SMARTpool) was pur-
chased from Dharmacon (Lafayette, CO). The siRNAs for ADAP-1, 
sense: CAAAUGUUGACCUGACGAAtt; ADAP-2, sense: GAGAU-
UUCAAGUUUGCCCUtt; Pyk2, sense: GAUGUGGUCCUGAAUC-
GUAtt; and control siRNA (Garcia-Bernal et al., 2005) were pur-
chased from Sigma-Aldrich. Vectors and siRNA were nucleofected 
(Amaxa, Cologne, Germany) following a previously described pro-
cedure (Garcia-Bernal et al., 2005). Molt-4 or PBL-T siRNA trans-
fectants were assayed 22–24 h posttransfection, and transfection 
did not affect cell viability, as assessed in cell cycle analyses by 
flow cytometry.
Cell adhesion and spreading assays
For static adhesions, we used the reported method (Garcia-
Bernal et al., 2005). Briefly, cells were plated in triplicate on wells 
coated with the fibronectin fragment FN-H89, which contains the 
CS-1 region, or with VCAM-1 together with CXCL12 or CCL21 
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(650 ng/ml), and plates were incubated and adhesion measured. 
Adhesion data are presented relative to control untreated cells, 
which have been given an arbitrary value of 100. For flow-cham-
ber adhesion assays, we followed the described protocol 
(Garcia-Bernal et al., 2006). In brief, cells were infused at a flow 
rate of 1 dyne/cm2 into flow chambers containing coimmobilized 
VCAM-1 and CXCL12. Rolling cells that subsequently firmly at-
tached were expressed as stable arrest, whereas tethering cells 
that did not arrest at any moment were expressed as rolling cells. 
For evaluation of shear resistance, cells were allowed to attach 
and then were subjected to sequential increases of the flow rate. 
The number of cells remaining bound was determined as the 
percentage of total adhered cells after the adhesion step. For 
cellular spreading, CXCL12-stimulated cells attached on VCAM-1 
were fixed and analyzed as previously described (Garcia-Bernal 
et al., 2006).
Soluble VCAM-1 binding and flow cytometry
For cell binding to VCAM-1-Fc (R&D Systems), cells were stimu-
lated for 20 s with CXCL12 before VCAM-1-Fc was added, which 
was detected by flow cytometry using phycoerythrin-conjugated 
AffiniPure F(ab′)2 fragment goat anti–human immunoglobulin G 
(IgG), Fcγ-fragment specific (Jackson ImmunoResearch, West 
Grove, PA). For the detection of high-affinity β1, cells were stimu-
lated for 20 s with CXCL12 before HUTS-21 anti–β1 mAb (10 μg/ml) 
was added for 30 min at 4ºC. After washing, cells were incubated 
with FITC-conjugated rabbit anti–mouse IgG (Jackson Immunore-
search). Fluorescence intensity data indicate fold-induction values 
relative to those from control untreated cells, which were given an 
arbitrary value of one.
Immunoprecipitation, immunoblotting, and GTPase assays
For immunoprecipitation, we followed the described method 
(Garcia-Bernal et al., 2009). In brief, cell lysate supernatants were 
incubated with antibodies followed by coupling to protein G-Sep-
harose. Proteins were separated by SDS–PAGE and transferred to 
membranes that were sequentially incubated with primary anti-
bodies and with horseradish peroxidase–conjugated secondary 
antibodies. Protein visualization was achieved using Immobilon 
Western chemiluminiscent substrate (Millipore). For GTPase as-
says, we used the reported method (Garcia-Bernal et al., 2005). 
Briefly, cells exposed to CXCL12 were lysed, and aliquots from 
extracts were separated for total lysate controls and for incuba-
tion with GST-PAK-CD fusion protein, followed by incubation with 
glutathione-Sepharose beads (GE Healthcare, Piscataway, NJ). 
Bound proteins were eluted and subjected to immunoblotting 
 using anti-Rac1 antibodies.
Statistical analyses
Data were analyzed by one-way analysis of variance, followed by 
Tukey-Kramer multiple comparisons. In both analyses, the minimum 
acceptable level of significance was p < 0.05.
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